Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The exposome and the developing adolescent brain: understanding mechanisms of neuroplasticity
    Published on 2025-09-17
    8 months ago
  • Standing firm: a lived experience perspective on Tourette’s Syndrome
    Published on 2025-09-15
    9 months ago
  • Brainwaves meet soundwaves: ultrasound stimulation for treating major depressive disorder by targeting the subcallosal cingulate cortex
    Published on 2025-09-15
    9 months ago
  • N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences
    Published on 2025-09-12
    9 months ago
  • Connectome harmonics: a novel method exploring the psychedelic experience
    Published on 2025-09-12
    9 months ago
  • Motor signs in late life depression relate to altered subcortical synaptic density and gray matter volume: an 11C-UCB-J PET-MR study
    Published on 2025-09-11
    9 months ago
  • From psychosis to creativity: a lived experience perspective on serious mental illness symptoms
    Published on 2025-09-10
    9 months ago
« Previous 1 … 31 32 33 34 35 … 143 Next »
Journal of Psychopharmacology
  • Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review
    Published on 2025-01-20
    1 year ago
  • A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
    Published on 2025-01-20
    1 year ago
  • Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study
    Published on 2025-01-07
    1 year ago
  • Haloperidol dopamine receptor occupancy and antagonism correspond to delirium agitation scores and EPS risk: A PBPK-PD modeling analysis
    Published on 2025-01-04
    1 year ago
  • Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study
    Published on 2025-01-02
    1 year ago
  • Brain serotonin, oxytocin, and their interaction: Relevance for eating disorders
    Published on 2025-01-02
    1 year ago
  • Commentary: A framework for assessment of adverse events in psychedelic research
    Published on 2024-12-30
    1 year ago
« Previous 1 … 31 32 33 34 35 … 146 Next »
European Neuropsychopharmacology
  • Respiratory health in serious mental illness
    Published on 2024-12-23
    1 year ago
  • Contrasting genetic burden for bipolar disorder: Early onset versus late onset in an older adult bipolar disorder sample
    Published on 2024-12-22
    1 year ago
  • Predicting the past: The risks and rewards of post-hoc findings
    Published on 2024-12-22
    1 year ago
  • Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disorders
    Published on 2024-12-22
    1 year ago
  • Redefining schizophrenia treatment with muscarinic modulation—A perspective
    Published on 2024-12-06
    1 year ago
  • Examining the impact of comorbid posttraumatic stress disorder on ketamine’s real-world effectiveness in treatment-resistant depression
    Published on 2024-12-06
    1 year ago
  • Dilemmas in psychedelic medicine: From ethics to regulation and equity
    Published on 2024-12-05
    1 year ago
« Previous 1 … 31 32 33 34 35 … 166 Next »

   Pharma Pub